Preparation of kakkatin derivatives and their anti-tumor activity

doi:10.5306/wjco.v15.i8.1078

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (511)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

HTML

247

Figures (1-7)

Tables (1-2)

Sum=301

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=144

Publishing Process of This Article

Item

Count

Browse

Download

Sum=59

Aug 24, 2024 (publication date) through Aug 27, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Aug 24, 2024; 15(8): 1078-1091
Published online Aug 24, 2024. doi: 10.5306/wjco.v15.i8.1078

Table 1 IC₅₀ value of kakkatin and 6-(hept-6-yn-1-yloxy)-3-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one on tumor Cells (μM)

Drug	SMMC-7721 cells	MGC803 cells
Cisplatin	17.54	20.83
Kakkatin	76.93	38.24
The 6-(hept-6-yn-1-yloxy)-3-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one	2.50	39.51

Citation: Jiang YY, Dong HH, Zhou WT, Luo JZ, Wei X, Huang YQ. Preparation of kakkatin derivatives and their anti-tumor activity. World J Clin Oncol 2024; 15(8): 1078-1091
URL: https://www.wjgnet.com/2218-4333/full/v15/i8/1078.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i8.1078